Company Profile

Belite Bio, Inc. (NASDAQ: BLTE)
9:00 PM UTC, 12/31/24
Last: $63.10 Change: +1.13 %Change: +1.82% Volume: 17,676
Detailed Quote
Open: $ 61.41   Volume: 17,676
High: $ 63.98   Yield(%) 0.00
Low: $ 61.41   P/E Ratio (ttm): n/a
Dividend ($): n/a   Market Cap ($): 1.95B
EPS ($) -1.11   Shares Out: 30.88M
M = Million B = Billion
Price Performance
% Price Change (last 4 weeks): -2.92
% Price Change (last 13 weeks): 33.52
% Price Change (last 26 weeks): 38.68
% Price Change (last 52 weeks): 47.57
% Price Change (year to date): 35.45
Management Effectiveness
Return on Equity (%): -47.95
Return on Assets (%): -45.54
Return on Invested Capital (%): -45.69
Profitability
Gross Profit Margin (%): n/a
Net Profit Margin (%): n/a
Operating Profit Margin (%): 0.00
Price & Volume
50-day Moving Average: $69.42
200-day Moving Average: $52.16
Avg. Daily Vol. (last 50 days): 81,179
Avg. Daily Vol. (last 200 days): 51,426
52-wk high: $86.53
52-wk low: $31.00
Bid: $61.61
Ask: $66.68
Company Information
Belite Bio, Inc. is a biopharmaceutical company engaged in the research and development of drugs. Its focus is on the treatment of eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease. It also caters to metabolic diseases such as non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, type 2 diabetes, and gout. The company was founded by Yu-Hsin Lin on March 27, 2018 and is headquartered in San Diego, CA.
Belite Bio, Inc.
12750 High Bluff Drive Suite 475
San Diego CA 92130

Phone: 1.858.246.6240
Fax: n/a
http://www.belitebio.com
Per Share Data
Earnings (1year) ($): -1.11
Annual Dividend ($): 0.00
Current P/E Ratio (ttm): n/a
Book Value ($): 3.10
Cash Flow ($): -1.07
Valuation Ratios
Price/Earnings (x): n/a
Price/Sales (x): n/a
Price/Book (x): 14.75
Price/Cash Flow (x): n/a
Financial Strength
Quick Ratio (x): 24.76
Current Ratio (x): 24.76
LT Debt/Equity (x): 0.64
Total Debt/Equity (x): 0.98



Quotes displayed with 15 minutes delay. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. News provided by MT Newswires, a Division of MidnightTrader, Inc. Events Data provided by Wall Street Horizon. ©2021 Wall Street Horizon, Inc.